Literature DB >> 30910631

Eosinophilic fasciitis: From pathophysiology to treatment.

Hironobu Ihn1.   

Abstract

Eosinophilic fasciitis is a disease originally proposed as "diffuse fasciitis with eosinophilia" by Shulman in 1974. The patients with this disease often have history of strenuous exercise or labor a few days to 1-2 weeks before the onset. The chief symptoms are symmetrical, full-circumference swelling and plate-like hardness of the distal limbs. This is accompanied by redness and pain in the early stages, with many cases exhibiting systemic symptoms such as fever or generalized fatigue. The lesions have been observed extending to the proximal limbs, though never on the face or fingers. En bloc biopsies from the skin to the fascia show marked fascial thickening and inflammatory cell infiltration by the lymphocytes and plasma cells. Eosinophilic infiltration is useful for the diagnosis but is only seen in the early stages of the disease. Recently, "Diagnostic criteria, severity classification, and clinical guidelines for eosinophilic fasciitis" were published. This review article discusses about eosinophilic faciitis in detail, from its pathophysiology to the treatment.
Copyright © 2019 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokines; Eosinophilia; Fibrosis; Hypergammaglobulinemia; Skin

Mesh:

Substances:

Year:  2019        PMID: 30910631     DOI: 10.1016/j.alit.2019.03.001

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  13 in total

1.  [Imaging of eosinophilic fasciitis in ultrasound and MRI (magnetic resonance imaging): a case report].

Authors:  Nicolas Gerritzen; Jana Ziob; Peter Brossart; Valentin S Schäfer
Journal:  Z Rheumatol       Date:  2022-05-16       Impact factor: 1.372

2.  Refractory eosinophilic fasciitis successfully treated with infliximab: A case report.

Authors:  Paulina Śmigielska; Justyna Czarny; Jacek Kowalski; Aleksandra Wilkowska; Roman J Nowicki
Journal:  J Scleroderma Relat Disord       Date:  2021-03-26

3.  Eosinophilic Fasciitis and Smoldering Multiple Myeloma: An Exceptional Association in Young Adults.

Authors:  Rajaa Jabbouri; Nouama Bouanani; Rita Aniq Filali; Jehanne Aasfara
Journal:  Cureus       Date:  2022-04-06

4.  Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice.

Authors:  Manja Newe; Theresa A Kant; Maximilian Hoffmann; Johanna S E Rausch; Luise Winter; Karolina Künzel; Erik Klapproth; Claudia Günther; Stephan R Künzel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-08-19       Impact factor: 3.195

5.  MRI Findings of Eosinophilic Fasciitis.

Authors:  Michaela Kubincová; Filip M Vanhoenacker
Journal:  J Belg Soc Radiol       Date:  2022-05-24       Impact factor: 1.912

6.  Lessons of the month 2: Connecting the clues: limb swelling and pain.

Authors:  Timothy Prossor; Kokul Sriskandarajah; Frederick W Vonberg; Melanie Dani
Journal:  Clin Med (Lond)       Date:  2020-01       Impact factor: 2.659

7.  Eosinophilic fasciitis in a pregnant woman with corticosteroid dependence and good response to infliximab.

Authors:  Nicolás Jiménez-García; Josefa Aguilar-García; Inés Fernández-Canedo; Nuria Blázquez-Sánchez; Rafael Fúnez-Liébana; Carlos Romero-Gómez
Journal:  Rheumatol Int       Date:  2021-01-23       Impact factor: 2.631

8.  Eosinophilic Fasciitis - Report of Three Cases and Review of the Literature.

Authors:  Uwe Wollina; Gesina Hansel; Jacqueline Schönlebe; Birgit Heinig; Ivanka Temelkova; Georgi Tchernev; Aleksandra Vojvocic; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2019-05-15

9.  Eosinophilia complicated with venous thromboembolism: A case report.

Authors:  Wei-Qiang Su; Yan-Zhong Fu; Shu-Yan Liu; Meng-Jie Cao; Ya-Bin Xue; Fei-Fei Suo; Wen-Chao Liu
Journal:  World J Clin Cases       Date:  2022-02-26       Impact factor: 1.337

Review 10.  Eosinophils in skin diseases.

Authors:  Susanne Radonjic-Hoesli; Marie-Charlotte Brüggen; Laurence Feldmeyer; Hans-Uwe Simon; Dagmar Simon
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.